title: Low flow nocturnal oxygen therapy does not suppress haemoglobin levels or increase painful crises in sickle cell disease.
authors: Hugh
authors: H
authors: Ip
authors: Rachel
authors: R
authors: Kesse-Adu
authors: Jo
authors: J
authors: Howard
authors: Nicholas
authors: N
authors: Hart
mesh_terms: D000328:Adult; D000755:Anemia, Sickle Cell / Q000150:complications* / Q000188:drug therapy; D000986:Antisickling Agents / Q000627:therapeutic use; D004920:Erythropoiesis; D004921:Erythropoietin / Q000097:blood; D005260:Female; D006454:Hemoglobins / Q000032:analysis*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D000860:Hypoxia / Q000209:etiology / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D010102:Oxygen Inhalation Therapy / Q000379:methods; D010146:Pain / Q000209:etiology / Q000517:prevention & control; D017701:Reticulocyte Count; D012189:Retrospective Studies; D020919:Sleep Disorders, Intrinsic / Q000628:therapy*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000986:Antisickling Agents; C554270:EPO protein, human; D006454:Hemoglobins; D004921:Erythropoietin; D006918:Hydroxyurea